Other Specialties
Same-Visit STI Testing. No Lab Send-Out Required.
The binx io is the world’s first FDA-cleared, CLIA-waived, molecular point-of-care platform for chlamydia (CT) and gonorrhea (NG), delivering PCR-accurate results in approximately 30 minutes with no laboratory or lab-trained staff required.4
Lab Turnaround Times Are
Costing You Patients
Send-out testing creates a 1–10 day window between testing and treatment, during which a significant share of patients never return. POC testing collapses that window to a single visit, directly improving treatment rates and reducing onward transmission.
-
2–10 days to resultPatient likely gone before results return
-
~40% lost to follow-upPatients who never return for treatment or results
-
Empiric antibiotic use Treatment decisions often made without confirmed diagnosis, undermining stewardship
-
Onward transmission risk Untreated patients continue spreading infection in the communit
-
~30 minutes to resultSame visit, same provider, same day
-
< 5% follow-up lossPatients who never return for treatment or results
-
Targeted, confirmed treatmentDiagnosis-driven prescribing supports antibiotic stewardshi
-
Reduced transmissionPatients treated in-visit leave with a confirmed result and prescription
Lab-Equivalent Accuracy in a Non-Lab Setting
| Chlamydia Sensitivity / Specificity |
Gonorrhea Sensitivity / Specificity |
|
|---|---|---|
| Female | 96.1% / 99.1% | 100.0% / 99.9% |
| Male | 92.5% / 99.3% | 97.3% / 100.0% |
It Fits Your Workflow
No lab staff, no certification, no complex setup. Fully automated with clear detected/not detected results, LIS/EMR integration, and an established reimbursement path for CT/NG point-of-care testing.
CLIA- Waived
No laboratory certification required. Any trained staff member can operate the instrument in a point-of-care setting.
Connectable
Ability to route directly into your existing systems. No manual transcription, no extra steps, no lag between result and clinical action.
Established reimbursement
CPT codes for CT/NG point-of-care testing are recognized by Medicare, Medicaid, and most commercial payers.
